| Announce Date | 08/07/2025 |
| EPS Normalized Actual | $0.66 (Beat by $0.23) |
| EPS GAAP Actual | $0.66 (Beat by $0.23) |
| Revenue Actual | $0.296527B |
| Revenue Surprise | Beat by $296.527M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $0.48 |
| EPS GAAP Estimate | $0.48 |
| Revenue Estimate | $0.3160424B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2026 | 2 | 9.94 | 1.82036 | 2.18438 | 1 |
| Dec 2025 | 1.43596 | 13.84 | 1.22 | 1.65193 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.3 | 0.3 | 0.296527B | 11.59% | 296.53M |
| FQ1 2025 (Mar 2025) | -0.39 | -0.39 | 0.198486B | -16.77% | 198.49M |
| FQ4 2024 (Dec 2024) | 1.59 | 1.59 | 0.372987B | 44.74% | 372.99M |
| FQ3 2024 (Sep 2024) | -1.09 | -1.09 | 0.159257B | -61.54% | 159.26M |
| FQ2 2024 (Jun 2024) | 0.61 | 0.61 | 0.262147B | 9.66% | 262.15M |
| FQ1 2019 (Mar 2019) | 0 | 0 | 0.131113B | 100% | 131.11M |
| FQ2 2019 (Jun 2019) | 0 | 0 | 0.131113B | 100% | 131.11M |
| FQ1 2024 (Mar 2024) | 0.47 | 0.47 | 0.231782B | 55.18% | 231.78M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
0.48
Consensus Revenue Estimates
0.3160424B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.5315 | -- | 0.50827 | 0.56142 | 1 |
| FQ3 2027 (Sep 2027) | 0.5447 | -- | 0.48751 | 0.57742 | 1 |
| FQ2 2027 (Jun 2027) | 0.4953 | -- | 0.44329 | 0.52505 | 1 |
| FQ1 2027 (Mar 2027) | 0.4342 | -- | 0.38861 | 0.46028 | 1 |
| FQ4 2026 (Oct 2026) | 0.5372 | -- | 0.4959 | 0.56683 | 0 |
| FQ3 2026 (Jul 2026) | 0.5114 | -- | 0.47208 | 0.53961 | 0 |
| FQ2 2026 (Jun 2026) | 0.5114 | 41.34 | 0.47144 | 0.56424 | 0 |
| FQ1 2026 (Mar 2026) | 0.4237 | 192.05 | 0.39059 | 0.46747 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.3B | -- | 0.29B | 0.31B | 1 |
| FQ3 2027 (Sep 2027) | 0.45B | -- | 0.41B | 0.47B | 2 |
| FQ2 2027 (Jun 2027) | 0.44B | -- | 0.41B | 0.46B | 2 |
| FQ1 2027 (Mar 2027) | 0.43B | -- | 0.4B | 0.45B | 2 |
| FQ4 2026 (Oct 2026) | 0.21B | -- | 0.2B | 0.22B | 1 |
| FQ3 2026 (Jul 2026) | 0.21B | -- | 0.2B | 0.22B | 1 |
| FQ2 2026 (Jun 2026) | 0.33B | 11.31 | 0.31B | 0.36B | 1 |
| FQ1 2026 (Mar 2026) | 0.33B | 39.46 | 0.31B | 0.35B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
4
EPS # of Misses
2
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | 0.3 | 0.3 | 100% | |
| FQ1 2025 (Mar 2025) | -0.39 | -0.39 | 100% | |
| FQ4 2024 (Dec 2024) | 1.59 | 1.59 | 100% | |
| FQ3 2024 (Sep 2024) | -1.09 | -1.09 | 100% | |
| FQ2 2024 (Jun 2024) | 0.61 | 0.61 | 100% | |
| FQ1 2019 (Mar 2019) | 0 | 0 | NAN% | |
| FQ2 2019 (Jun 2019) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0.47 | 0.47 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ2 2025 (Jun 2025) | $0B | $0.3B | $296.53M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.2B | $198.49M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.37B | $372.99M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.16B | $159.26M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.26B | $262.15M | 100% |
| FQ1 2019 (Mar 2019) | $0B | $0.13B | $131.11M | 100% |
| FQ2 2019 (Jun 2019) | $0B | $0.13B | $131.11M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.23B | $231.78M | 100% |